I Can't Ignore These Troubling Signs...

This stock has soared in 2024, but I have some concerns. [Shield] AN OXFORD CLUB PUBLICATION [Wealthy Retirement]( [View in browser]( SPONSORED Could Elon Musk's New Project Be Worth Trillions of Dollars? Elon Musk has predicted that his new venture["X-9840" could be "a multi-trillion dollar company..."]( As big as Microsoft... Apple... and Nvidia... Companies gave their early investors a chance to become millionaires over the long term, starting with just $1,000. [Click here to see the details]( because this has nothing to do with electric vehicles... self-driving cars, rockets, brain chips, or satellites. [THE VALUE METER]( [Organon Continues to Burn Cash at an Alarming Rate]( [Anthony Summers, Director of Trading, The Oxford Club]( [Anthony Summers]( Last week, a reader requested that I take a look at Organon (NYSE: OGN), which spun off from pharmaceutical giant Merck in 2021. Organon has hit the ground running with a diverse portfolio of women's health products, including its flagship product, Nexplanon - a long-acting reversible contraceptive implant. It's also working on treatments for conditions like endometriosis and polycystic ovary syndrome. The company is aiming to capitalize on the growing market for biosimilars, which are lower-cost alternatives to biologic drugs. It also has an "established brands" business that produces cash flow from well-known drugs that have lost patent protection. Overall, Organon has an interesting business model that blends the potential high growth of women's health and biosimilars with the stability of established brands. Speaking of high growth, the stock has just about doubled year to date. [Chart: Organon (NYSE: OGN)]( [View larger image]( But as we'll see, the financials tell a more complicated story. First, let's examine Organon's enterprise value-to-net asset value (EV/NAV) ratio. As always, this metric gives us a sense of how the market is valuing the company relative to its assets. Organon's EV/NAV sits at an eye-popping -1,215.7, which is nearly 11 times worse than the average of -111.2 for companies with negative net assets. We typically compare our Value Meter stocks with companies that have positive net assets, so you might be wondering why we're looking at companies with negative net assets today. The reason is simple: It's not uncommon for younger companies to have more liabilities than assets as they grow and invest in the future, so I wanted to compare Organon with the companies it's most similar to. Even so, Organon's situation is far more extreme than most - especially when you consider its cash flow generation. In three out of the last four quarters, Organon has burned through cash faster than a California wildfire. On average, its free cash flow was -99.6% of its net assets over those four quarters. For context, the average for similar companies was just -5.3%. While that's still not great, it's a far cry from Organon's cash bonfire. It's like comparing a leaky faucet to Niagara Falls. Organon did, however, manage to report some solid numbers in the first quarter of this year... Are they enough to salvage the stock's valuation? [Get My Verdict Here]( [Investment U Conference 2025 - Ponte Vedra Inn & Club in Ponte Vedra Beach, Florida, March 30-April 2, 2025]( SPONSORED [The Ultimate Passive Income Play]( [isometric happy businessman and money working]( The #1 income play for 2024 is NOT a stock, bond or private company... Rather, it's a [little-known alternative investment]( that could hand you big monthly income from oil and gas. [Find Out What It Is Right Here]( BUILD AND PROTECT YOUR WEALTH [Here are Three Steps You Need to Take to Protect and Grow Your Money When America Is Threatened With Mass Unemployment. Watch This Before AI Goes Supernova.]( [Is Degrowth in Our Future?]( [This uber-successful hedge fund CEO has been investing since he was 12... and these are HIS THREE picks for 2024's top stocks]( [Could This Be the Best Insider Stock for 2024?]( MORE FROM WEALTHY RETIREMENT [Article]( [Innovative Industrial Properties: A True “High” Yielder]( [Article]( [The Hidden Truth About Diversification]( [Article]( [Follow the Insiders to Gain an Edge Over the Market]( [Article]( [Is Cava’s Sizzling Stock Too Hot to Handle?]( [Facebook]( [Facebook]( [LinkedIn logo]( [LinkedIn]( [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AThis healthcare stock has nearly doubled in 2024... but there are some warning signs that are difficult to ignore.%0D%0A%0D [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AThis healthcare stock has nearly doubled in 2024... but there are some warning signs that are difficult to ignore.%0D%0A%0D [Push Alert]( [Push Alert]( SPONSORED [Yours Free! Top FIVE Dividend Stocks Right Now]( Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... - An "A"-rated, ultra-safe dividend stock with a huge 8% yield - Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income - And finally, Marc's No. 1 dividend stock for a LIFETIME of income. [Click here to get the names and ticker symbols now](... before the download link expires. **NO CREDIT CARD REQUIRED!** [The Oxford Club]( You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Wealthy Retirement]( | [Unsubscribe]( © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [877.808.9795](#) | International: [+1.443.353.4621](#) [Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.